New Pathways in the Treatment of DMD
Erika Finanger, MD, MS
Aravindhan Veerapandiyan, MD
Mechanism-Driven gMG Therapy: FcRn Antagonists and the Rise of Precision Neurology
Neelam Goyal, MD
Christyn Edmundson, MD
Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
Marwan Sabbagh, MD, FAAN
Alireza Atri, MD, PhD
Christoph U. Correll, MD
Treatment of a Broader Population of Patients With DMD
Crystal Proud, MD
Recognizing Early Signs of LGMD2I/R9
John Vissing, MD, DMSci
Optimizing Patient Management Strategies
Integrating Perspectives: The Value of Patient and Caregiver Input
Conrad Weihl, MD, PhD
Navigating the LGMD2I/R9 Diagnostic Pathway
Bridging Gaps in LGMD Care
Epilepsy: Beyond Seizure Impact
Raman Sankar, MD, PhD
Scott Aaronson, MD
Optimizing VNS Parameters: Keys to Therapeutic Success
Modern Neuromodulation: Vagus Nerve Stimulation in Advancing Care for Patients With Drug-Resistant Epilepsy and Treatment-Resistant Depression
New Frontiers in the Treatment of DMD Across the Age Spectrum
John Brandsema, MD
Omer Abdul Hamid, MD
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
James R. Bateman, MD, MPH
B. Joy Snider, MD, PhD
Jerome A. Barakos, MD
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
Charles P. Vega, MD
Clinical Conundrums in ARIA: How to Manage Severe ARIA
Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.